TLR9 signaling influences the expression of inflammasome in macrophages, resulting in the formation of proinflammatory IL-1β and enhancing the progression of hepatic injury in MASH. The gene discussed is TLR9; the disease is metabolic dysfunction-associated steatohepatitis.